FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170363268> ?p ?o ?g. }

• W2170363268 endingPage "496" @default.
• W2170363268 startingPage "490" @default.
• W2170363268 abstract "Background. Taste alterations (TAs) are frequently reported by chemotherapy patients. However, research on this topic is very scarce. The etiologies of TAs are not fully known and prevalences may vary across tumour types and chemotherapy regimens. The aim of the present study was to longitudinally investigate TAs in patients with breast cancer or gynaecological cancers receiving chemotherapy, and to provide expected values for TAs for these patient populations. Patients and methods. One hundred and nine cancer patients (32.1% gynaecological cancer, 67.9% breast cancer) receiving chemotherapy at the Department for Internal Medicine of Kufstein County Hospital were consecutively included in the study. At each visit the Quality of Life Questionnaire-Core30 and a screening scale for TAs, consisting of two validated questions taken from the European Organisation for Research and Treatment of Cancer item bank was administered. Statistical analysis was performed using mixed-effect models. Results. The prevalence of TAs in breast cancer and gynaecological cancer patients receiving chemotherapy was high (76.1%). There were differences in the extent of TAs as well as in their time course across treatment groups. The lowest TAs were found in breast cancer and gynaecological cancer patients treated with gemcitabine. The highest TAs were found in breast cancer patients treated with epirubicin/docetaxel/capecitabine. The steepest increase of TAs was found in patients treated with epirubicin/docetaxel. Moreover, significant associations between TAs and appetite loss as well as fatigue were found. Conclusion. The results show that TAs are an issue in breast and gynaecological cancer patients receiving different chemotherapy regimens. There is a need for a more systematic investigation of TAs in chemotherapy patients in general as well as the need to address this issue in clinical practice." @default.
• W2170363268 created "2016-06-24" @default.
• W2170363268 creator A5000811638 @default.
• W2170363268 creator A5022499341 @default.
• W2170363268 creator A5028574419 @default.
• W2170363268 creator A5032861326 @default.
• W2170363268 creator A5066339781 @default.
• W2170363268 creator A5067420156 @default.
• W2170363268 creator A5077717126 @default.
• W2170363268 creator A5079917470 @default.
• W2170363268 creator A5087125819 @default.
• W2170363268 date "2011-11-30" @default.
• W2170363268 modified "2023-09-27" @default.
• W2170363268 title "Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: Prevalence, course of severity, and quality of life correlates" @default.
• W2170363268 cites W1972744209 @default.
• W2170363268 cites W1975864206 @default.
• W2170363268 cites W1988915643 @default.
• W2170363268 cites W1989717470 @default.
• W2170363268 cites W2020338198 @default.
• W2170363268 cites W2036927649 @default.
• W2170363268 cites W2038706422 @default.
• W2170363268 cites W2048365920 @default.
• W2170363268 cites W2049047554 @default.
• W2170363268 cites W2053339297 @default.
• W2170363268 cites W2057514760 @default.
• W2170363268 cites W2060913534 @default.
• W2170363268 cites W2066352427 @default.
• W2170363268 cites W2066421899 @default.
• W2170363268 cites W2074439075 @default.
• W2170363268 cites W2078445443 @default.
• W2170363268 cites W2086308175 @default.
• W2170363268 cites W2091566371 @default.
• W2170363268 cites W2094862546 @default.
• W2170363268 cites W2106521963 @default.
• W2170363268 cites W2107611570 @default.
• W2170363268 cites W2124443610 @default.
• W2170363268 cites W2129187957 @default.
• W2170363268 cites W2130941707 @default.
• W2170363268 cites W2136607280 @default.
• W2170363268 cites W2138361287 @default.
• W2170363268 cites W2167571044 @default.
• W2170363268 cites W2170982929 @default.
• W2170363268 doi "https://doi.org/10.3109/0284186x.2011.633554" @default.
• W2170363268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22129358" @default.
• W2170363268 hasPublicationYear "2011" @default.
• W2170363268 type Work @default.
• W2170363268 sameAs 2170363268 @default.
• W2170363268 citedByCount "47" @default.
• W2170363268 countsByYear W21703632682012 @default.
• W2170363268 countsByYear W21703632682013 @default.
• W2170363268 countsByYear W21703632682014 @default.
• W2170363268 countsByYear W21703632682015 @default.
• W2170363268 countsByYear W21703632682016 @default.
• W2170363268 countsByYear W21703632682017 @default.
• W2170363268 countsByYear W21703632682018 @default.
• W2170363268 countsByYear W21703632682019 @default.
• W2170363268 countsByYear W21703632682020 @default.
• W2170363268 countsByYear W21703632682021 @default.
• W2170363268 countsByYear W21703632682022 @default.
• W2170363268 countsByYear W21703632682023 @default.
• W2170363268 crossrefType "journal-article" @default.
• W2170363268 hasAuthorship W2170363268A5000811638 @default.
• W2170363268 hasAuthorship W2170363268A5022499341 @default.
• W2170363268 hasAuthorship W2170363268A5028574419 @default.
• W2170363268 hasAuthorship W2170363268A5032861326 @default.
• W2170363268 hasAuthorship W2170363268A5066339781 @default.
• W2170363268 hasAuthorship W2170363268A5067420156 @default.
• W2170363268 hasAuthorship W2170363268A5077717126 @default.
• W2170363268 hasAuthorship W2170363268A5079917470 @default.
• W2170363268 hasAuthorship W2170363268A5087125819 @default.
• W2170363268 hasBestOaLocation W21703632681 @default.
• W2170363268 hasConcept C121608353 @default.
• W2170363268 hasConcept C126322002 @default.
• W2170363268 hasConcept C143998085 @default.
• W2170363268 hasConcept C159110408 @default.
• W2170363268 hasConcept C2776694085 @default.
• W2170363268 hasConcept C2777909004 @default.
• W2170363268 hasConcept C2779951463 @default.
• W2170363268 hasConcept C2780258809 @default.
• W2170363268 hasConcept C2780835546 @default.
• W2170363268 hasConcept C2781190966 @default.
• W2170363268 hasConcept C29456083 @default.
• W2170363268 hasConcept C526805850 @default.
• W2170363268 hasConcept C530470458 @default.
• W2170363268 hasConcept C71924100 @default.
• W2170363268 hasConceptScore W2170363268C121608353 @default.
• W2170363268 hasConceptScore W2170363268C126322002 @default.
• W2170363268 hasConceptScore W2170363268C143998085 @default.
• W2170363268 hasConceptScore W2170363268C159110408 @default.
• W2170363268 hasConceptScore W2170363268C2776694085 @default.
• W2170363268 hasConceptScore W2170363268C2777909004 @default.
• W2170363268 hasConceptScore W2170363268C2779951463 @default.
• W2170363268 hasConceptScore W2170363268C2780258809 @default.
• W2170363268 hasConceptScore W2170363268C2780835546 @default.
• W2170363268 hasConceptScore W2170363268C2781190966 @default.
• W2170363268 hasConceptScore W2170363268C29456083 @default.
• W2170363268 hasConceptScore W2170363268C526805850 @default.
• W2170363268 hasConceptScore W2170363268C530470458 @default.

• next